Anti-Cytochrome P450 3A4/CYP3A4 抗体 (ab135813)
製品の概要
-
製品名
Anti-Cytochrome P450 3A4/CYP3A4 antibody
Cytochrome P450 3A4/CYP3A4 一次抗体 製品一覧 -
製品の詳細
Rabbit polyclonal to Cytochrome P450 3A4/CYP3A4 -
由来種
Rabbit -
アプリケーション
適用あり: Flow Cyt, IHC-P, WBmore details -
種交差性
交差種: Human -
免疫原
Synthetic peptide corresponding to Human Cytochrome P450 3A4/CYP3A4 aa 234-264 (internal sequence) conjugated to keyhole limpet haemocyanin.
-
ポジティブ・コントロール
- Human liver tissue; CEM cells; NCI-H460 cell line lysates.
-
特記事項
This product was previously labelled as Cytochrome P450 3A4
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. -
バッファー
Preservative: 0.09% Sodium azide
Constituent: 99% PBS -
Concentration information loading... -
精製度
Ammonium Sulphate Precipitation -
特記事項(精製)
ab135813 is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS. -
ポリ/モノ
ポリクローナル -
アイソタイプ
IgG -
研究分野
関連製品
-
Compatible Secondaries
-
Conjugation kits
-
Isotype control
-
Recombinant Protein
アプリケーション
Our Abpromise guarantee covers the use of ab135813 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| アプリケーション | Abreviews | 特記事項 |
|---|---|---|
| Flow Cyt | 1/10 - 1/50. ab171870 - Rabbit polyclonal IgG, is suitable for use as an isotype control with this antibody.
|
|
| IHC-P | 1/10 - 1/50. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol. | |
| WB | 1/50 - 1/100. Predicted molecular weight: 57 kDa. |
ターゲット情報
-
機能
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It performs a variety of oxidation reactions (e.g. caffeine 8-oxidation, omeprazole sulphoxidation, midazolam 1'-hydroxylation and midazolam 4-hydroxylation) of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. The enzyme also hydroxylates etoposide. -
組織特異性
Expressed in prostate and liver. According to some authors, it is not expressed in brain (PubMed:19094056). According to others, weak levels of expression are measured in some brain locations (PubMed:19359404 and PubMed:18545703). Also expressed in epithelium of the small intestine and large intestine, bile duct, nasal mucosa, kidney, adrenal cortex, epithelium of the gastric mucosa with intestinal metaplasia, gallbladder, intercalated ducts of the pancreas, chief cells of the parathyroid and the corpus luteum of the ovary (at protein level). -
配列類似性
Belongs to the cytochrome P450 family. -
翻訳後修飾
Polyubiquitinated in the presence of AMFR and UBE2G1 and also STUB1/CHIP and UBE2D1 (in vitro). -
細胞内局在
Endoplasmic reticulum membrane. Microsome membrane. - Information by UniProt
-
参照データベース
- Entrez Gene: 1576 Human
- Omim: 124010 Human
- SwissProt: P08684 Human
- Unigene: 728751 Human
-
別名
- 1,8-cineole 2-exo-monooxygenase antibody
- Albendazole monooxygenase antibody
- Albendazole sulfoxidase antibody
see all
画像
-
All lanes : Anti-Cytochrome P450 3A4/CYP3A4 antibody (ab135813) at 1/50 dilution
Lane 1 : NCI-H460 cell line lysates
Lane 2 : NCI-H460 cell line lysates with blocking peptide
Lysates/proteins at 35 µg per lane.
Predicted band size: 57 kDa -
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytochrome P450 3A4/CYP3A4 antibody (ab135813)Immunohistochemical analysis of Formalin-fixed, Paraffin-embedded Human liver tissue labelling Cytochrome P450 3A4/CYP3A4 with ab135813 at 1/10 dilution followed by peroxidase-conjugated secondary antibody and DAB staining.
-
Flow Cytometric analysis of CEM cells labelling Cytochrome P450 3A4/CYP3A4 with ab135813 at 1/10 dilution (right histogram) compared to a negative control cell (left histogram). FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.
参考文献
This product has been referenced in:
- Danoy M et al. Optimized protocol for the hepatic differentiation of induced pluripotent stem cells in a fluidic microenvironment. Biotechnol Bioeng 116:1762-1776 (2019). Read more (PubMed: 30883676) »
- Chang YT et al. Role of CYP3A4 in bone marrow microenvironment-mediated protection of FLT3/ITD AML from tyrosine kinase inhibitors. Blood Adv 3:908-916 (2019). Read more (PubMed: 30898762) »

